Explore the full directors' dealings record of IRLAB Therapeutics AB, a listed issuer based in Finland. Shares are listed on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, IRLAB Therapeutics AB has recorded 2 reports. Market capitalisation: €107.7m. The latest transaction was filed on 28 November 2025 (Purchase). Among the most active insiders: Joakim Tedroff. All data is free.